Introduction {#sec1}
============

Empathy is a complex psychological construct that refers to the ability of individuals to share the experience of others (Batson, [@ref1]; Cuff *et al.*, [@ref15]; Coll *et al.*, [@ref11]). It is of high importance for healthy interactions with others and has been suggested to be altered in several psychiatric conditions (Decety and Moriguchi, [@ref25]; Bird and Viding, [@ref2]). With the hope that understanding the neuronal mechanisms of empathy will bring new insights on this concept, it has been one of the main endeavours of social neuroscience to describe the cerebral processes and computations underlying empathy (Decety and Jackson, [@ref22]; de Vignemont and Singer, [@ref21]; Klimecki and Singer, [@ref50]).

While it is challenging to elicit empathy in a controlled neuroimaging experiment, studies often use cues of nociceptive stimulation in others (i.e. a needle piercing a hand) to study empathy since they are relatively unambiguous, highly salient and easily understood (Vachon-Presseau *et al.*, [@ref77]). In the electroencephalography (EEG) literature, the event-related potential (ERP) technique has mostly been used to study this phenomenon by measuring electrical brain responses to nociceptive cues depicting various levels of pain in others. In a seminal study, Fan and Han ([@ref30]) showed participants real pictures or cartoon depictions of hands in painful or neutral situations and asked participants to either judge the intensity of the pain experienced or to count the number of hands present in the stimuli. The results showed an early effect of pain in the N1 and N2 components that was not influenced by task demands and a latter effect of pain in the P3 component that was modulated by task requirements. The authors interpreted these results as the presence of an early automatic response indexing emotional sharing and a late response indexing the cognitive evaluation of others' pain (Fan and Han, [@ref30]).

This framework is now regularly used to study pain empathy in healthy and clinical samples. Broadly, the main results from these studies suggest that these ERP components reflect sensitivity to pain in others. Indeed, both early and late ERP components in response to vicarious pain have been related to self-reported trait empathy (Corbera *et al.*, [@ref14]; Fabi *et al.*, [@ref28]; Vaes *et al.*, [@ref78]) and to the intensity and unpleasantness of the pain perceived in others (Decety *et al.*, [@ref26]; Cheng *et al.*, [@ref8]; Meng *et al.*, [@ref59]). The differentiation between ERP to pain and neutral stimuli is decreased when task demands interfere with the processing of the pain stimuli (Fan and Han, [@ref30]; Kam *et al.*, [@ref47]; Cui *et al.*, [@ref19] ) and increased when task demands favour a deeper processing (Li *et al.*, [@ref54]; Ikezawa *et al.*, [@ref43]). The nature of the target depicted in the stimuli has also been shown to influence early and late ERP responses, with decreased responses for cartoon depiction of pain (Fan and Han, [@ref30]), pain inflicted to robots' hands (Suzuki *et al.*, [@ref76]) and to individuals of a different race (Sessa *et al.*, [@ref73]; Contreras-Huerta *et al.*, [@ref12]; Fabi *et al.*, [@ref85]). In psychopathology research, this paradigm was predominantly used with persons suffering from schizophrenia and indicates that compared to healthy controls, patients with schizophrenia show a decreased capacity to initiate and regulate their empathic response (Ikezawa *et al.*, [@ref42]; Gonzalez-Liencres *et al.*, [@ref34]).

However, the reliability and relevance of these results are unclear. Indeed, studies using this paradigm are often plagued by several methodological issues commonly observed in ERP research. For example, in the initial study by Fan and Han ([@ref30]), the authors analysed multiple time windows at several scalp locations and performed over 100 statistical tests on ERP data without adjusting the significance threshold for those multiple comparisons. This suggests that some of the results have a high probability of being false positives (Kilner, [@ref49]) and that the effect of vicarious pain observation on ERP therefore deserves further scrutiny.

The issue of multiple comparisons is a common problem in neuroimaging studies due to the large amount of data collected (Poldrack *et al.*, [@ref67]; Luck and Gaspelin, [@ref55]). In the ERP literature, this is often made worse by the traditional use of factorial analyses performed in several time windows and at several scalp locations without clear hypotheses on the main effects and interactions (Luck and Gaspelin, [@ref55]). Furthermore, this large amount of data also allows for considerable analytical flexibility; that is, the idea that the same data set can be analysed in different ways with significant changes in the results and interpretations depending on the analytical pipeline chosen (Carp, [@ref5]). The presence of flexibility in design and analysis choices and ambiguity regarding how to best make these choices can lead researchers to compare the results of different analytical pipelines and choose the one that gives the most favourable pattern of result (Simmons *et al.*, [@ref74]; Carp, [@ref5]). When considerable analytical variability is present in a particular field without justification, it can raise doubt regarding the validity of the results and their interpretations.

If the study of pain empathy using ERP is to provide results that are appropriate to further our understanding of empathy in different contexts and populations, it seems imperative to assess (i) the reliability of the effect of the observation of pain in others on the ERP response and (ii) the amount of variability and flexibility in the designs employed to investigate this phenomenon. To reach these aims, a review of the methodological practices used in 40 ERP studies investigating pain empathy and a meta-analytical compilation of their results was performed. The results provide meta-analytical evidence for the association between late ERP components and the observation of pain in others. However, there was considerable variation in the design and analyses and incomplete reporting of results, raising doubts on the validity of these results.

Methods {#sec2}
=======

Study selection {#sec3}
---------------

A systematic review of the literature was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher *et al.*, [@ref61]). The articles included in this review were selected by searching *PubMed* for studies that were available online before 1 May 2018 using different combinations of keywords (e.g. 'EEG', 'ERP', 'pain', 'empathy', 'vicarious', see [Supplementary Table S1](https://osf.io/h6n4v)). The reference lists and citation reports of eligible studies were also consulted.

To be included in this report, studies had to report scalp ERP data in response to pictures depicting nociceptive stimulations (e.g. Jackson *et al.*, [@ref45]). Studies using facial expressions stimuli were included only when nociceptive stimulations were visible in the stimuli (e.g. needle piercing the skin of the face). This procedure led to the selection of 40 studies published between 2008 and 2018 in 20 different journals ([Supplementary Table S1](https://osf.io/h6n4v), [Table 2](#TB2){ref-type="table"} and asterisks in the Reference list).

From the 40 studies reviewed, four were excluded from quantitative the meta-analysis. One was excluded because it used the same data set and analyses as another study (Han *et al.*, [@ref38]), one because it did not report sufficient information (Ikezawa *et al.*, [@ref43]), one because it used non-parametric statistics (Fitzgibbon *et al.*, [@ref32]) and one because it reported incorrect degrees of freedom and F statistics (Sun *et al.*, [@ref75]). The quantitative meta-analysis was therefore performed on 36 studies (marked with double asterisks in the References). The PRISMA flowchart for study selection and rejection is shown in [Figure 1](#f1){ref-type="fig"}. The data reported in this review were manually extracted from the text of the published articles or accompanying Supplementary Materials and available in Supplementary [Table S1](https://osf.io/h6n4v).

![PRISMA flowchart. Reasons for exclusions are shown in [Table S1](https://osf.io/h6n4v).](nsy072f1){#f1}

Methodological review {#sec4}
---------------------

Several variables concerning the participants, materials and procedures, data collection and preprocessing, ERP measurements, statistical analyses and the reporting of results were collected and summarised below. When information was not clearly reported, the value was estimated based on the available information or assumed to have a particular value (e.g. when no post-hoc correction was reported, it was assumed that none were used). When insufficient information was available for a particular variable, it was marked as not reported and treated as a missing value. In order to assess the exhaustiveness of the hypotheses formulated regarding ERPs in each study, hypotheses were classified in one of four categories: *Complete*, *Partial*, *Alternative* and *None*. Hypotheses were rated as *Complete* if they clearly predicted the specific components that were expected to be influenced by all manipulations as well as the direction and the location of this effect. If some predictions were present but were incomplete or unclear, the hypothesis was rated as *Partial*. Hypotheses that were formulated as two alternative outcomes without a clear prediction were labelled *Alternative* and the absence of prediction regarding ERP effects was labelled *None*. This procedure was applied separately for the factorial analysis of variance (ANOVA) performed on ERP components and for the correlational analysis of ERP components with other variables.

Meta-analysis of ERP components {#sec5}
-------------------------------

A quantitative meta-analysis was carried out to assess the evidence for a modulation of different ERP components by the observation of pain. However, this was complicated by the fact that most studies reviewed reported only significant results (section *Results reporting*) and the general lack of clarity and precision of the results section of many studies. Nevertheless, when possible, F-values for the omnibus repeated measures test comparing the ERP response to pain and neutral stimuli were collected for each study.

When several between-subject and within-subject factors were manipulated, the F-value of the baseline condition was selected when available (e.g. in healthy controls or following neutral priming). Similarly, when available, the F-values for individual electrodes were collected. However, in most cases, the omnibus F-value from the main effect of pain in a multi-factorial analysis was collected and attributed to all electrodes included in the analysis. When mean amplitudes and standard deviations or standard errors were reported, the paired sample *t*-value for the pain effect was calculated assuming a correlation of 0.70 between measurements. When only the exact *P*-value was reported, the corresponding *t*-value was found using the *t* distribution. Following available guidelines (Cooper and Hedges, [@ref13]; Moran *et al.*, [@ref62]), when the effect was reported as non-significant without the information necessary to compute an effect size, the effect size was calculated assuming *P* = 0.5. This was done for each of the most frequently analysed components \[N1, N2, P3 and the late positive potential (LPP)\]. All F-values were subsequently converted to *t*-values by taking their square root (Brozek and Alexander, [@ref4]). In order to compare the effect sizes across studies, the *t*-values collected for each electrode and component were converted to Hedges's *g*, a standardised measure of difference that is less biased than Cohen's *d*, especially for small samples (Hedges, [@ref86]). Effects were scored as positive when the observation of pain led to increased ERP amplitude (i.e. more positive) than the observation of neutral stimuli and as negative when the ERP amplitude was more positive in response to neutral stimuli compared to pain stimuli.

Effect sizes were summarised in different ways. First, the spatial distribution of the effects was assessed by plotting scalp maps of the weighted absolute effect size for each component of interest. The absolute effect was taken to show where the effects were stronger on the scalp independently of their direction. The average effect at each electrode was also weighted by the number of studies including this electrode in their analysis in order to down-weight the effects at electrodes that were only analysed in a small number of studies. Second, the proportion of significant effects and significant interactions with other factors was compiled for each component. Third, a random effect meta-analysis was performed for each component at fronto-central (Fz, FCz, F1, F2, F3, F4, FC1, FC2, FC3, FC4), centro-parietal (Cz, CPz, C1, C2, C3, C4, CP1, CP2, CP3, CP4) and parieto-occipital (Pz, POz, P1, P2, P3, P4, PO1, PO2, PO3, PO4) electrode clusters to estimate summary effect size and the heterogeneity across studies. Finally, potential publication bias was assessed using funnel plots and regression tests (Egger *et al.*, [@ref27]). To assess potential excess significance, the number of studies finding a significant effect for each component was compared to the expected number of significant studies given the power of each study to detect the summary effect size using exact one-tailed binomial tests and a significance threshold of 0.10 (Ioannidis and Trikalinos, [@ref44]).

Data availability {#sec6}
-----------------

All data and scripts used to produce this manuscript and accompanying figures, the PRISMA guidelines checklist and supplementary information and figures are available online at [https:/osf.io/xtm5c/](https://osf.io/xtm5c/). All data processing and analyses were performed using *Rstudio* (RStudio Team, 2015; R Core Team, [@ref69]) and the Fieldtrip toolbox (Oostenveld *et al.*, [@ref64]) within Matlab R2017a (The MathWorks, Inc., Natick, Massachusetts, United States).

Systematic review of methodological practices {#sec7}
=============================================

Goals and hypotheses {#sec8}
--------------------

All studies reviewed aimed at comparing the effect of an experimental manipulation and/or participant characteristics on the ERP to pain stimuli with the goal of furthering the understanding of the mechanisms underlying empathy in the general population and/or in various clinical groups. As shown in [Table 1](#TB1){ref-type="table"}, the majority of studies presented incomplete hypotheses regarding the analysis of ERP components. While some studies provided complete hypothesis for the factorial analysis of ERPs, this was rarely the case for correlational analyses of ERP and other behavioural or physiological variables, suggesting that most of these analyses were exploratory in nature.

###### 

Ratings of the exhaustiveness of hypotheses for the factorial and correlational analyses of ERP data

  Judgement of hypothesis   Factorial analyses on ERP data (% of 40 studies)   Correlations with ERP data (% of 26 studies)
  ------------------------- -------------------------------------------------- ----------------------------------------------
  None                      10                                                 69.23
  Partial                   50                                                 26.92
  Complete                  22.5                                               0
  Alternative               17.5                                               3.85

Participants {#sec9}
------------

In the 40 studies reviewed, 42.5% used a between-subject design and 57.5% used a within-subject design. Among studies employing a between-subject design, 22.5% compared participants from the general population to participants from a clinical group. These clinical conditions included autism, amputation, bipolar disorder, fibromyalgia, juvenile delinquents and schizophrenia. Only two studies provided a justification for their sample size based on a priori power analyses. The average sample size, sample size per group and participants excluded are shown in [Table 2](#TB2){ref-type="table"}. In order to assess the power of each study to detect a small (*d* = 0.2), medium (*d* = 0.5) or large (*d* = 0.8) effect size (Cohen, [@ref9]), a power analysis was performed for each study and each of these effect size using the sample size per group, a two-sided paired *t*-test and a significance threshold of 0.05. As shown in [Figure 2](#f2){ref-type="fig"}, most studies were only adequately powered to detect a large effect size equal to or higher than *d* = 0.8. No studies had 80% power to detect a small or medium effect size.

###### 

Main design, task and EEG characteristics for each study reviewed

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                Between subjects   Sample size (total)   Number of exclusions   Sample size (per group)   Clinical sample            Task type             Stimulus type   Simulus duration (ms)   Number of conditions   Number of trials per condition   Number of electrodes   EEG reference       Components analysed
  ------------------------------------ ------------------ --------------------- ---------------------- ------------------------- -------------------------- --------------------- --------------- ----------------------- ---------------------- -------------------------------- ---------------------- ------------------- --------------------------------------------
  Chen *et al.,*[@ref6]                No                 28                    2                      28                                                   Passive observation   Dynamic limbs   1000                    4                      64                               64                     Average reference   N260, N360, LPP

  Cheng *et al.,*[@ref8]               Yes                43                    2                      14.33                     Juvenile\                  Pain detection        Static limbs    1000                    4                      40                                                      Single mastoid      N120, P3, N360, LPP
                                                                                                                                 delinquents                                                                                                                                                                                 

  Cheng *et al.,*[@ref7]               Yes                72                    22                     8.5                                                  Passive observation   Dynamic limbs   2050                    2                      80                               32                     Average mastoids    EAC, LPP

  Coll *et al.,*[@ref11]               Yes                48                    2                      16                                                   Pain assessment       Static limbs    2500                    4                      40                               128                    Average reference   N200, P2, LPP

  Contreras-Huerta *et al.,*[@ref12]   No                 21                    0                      21                                                   Pain detection        Static faces    1000                    8                      96                               64                     Average reference   N1, P3, N170, VPP, P2

  Corbera *et al.,*[@ref14]            Yes                37                    0                      18.5                      Schizophrenia              Pain detection        Static limbs    500                     4                      204                              32                     Average mastoids    N110, P180, N240, LPP

  Cui *et al.,*[@ref17]                No                 20                    3                      20                                                   Other                 Static limbs    1000                    4                      120                              63                     Average reference   N1, P2, N2, P3, LPP

  Cui *et al.,*[@ref16]                No                 28                    0                      28                                                   Passive observation   Static limbs    1000                    6                      60                               63                     Average reference   N1, P2, N2, P3, LPC

  Cui *et al.,*[@ref18]                No                 23                    3                      20                                                   Other                 Static limbs    1000                    8                      110                              63                     Average reference   N1, N2, P3

  Cui *et al.,*[@ref84]                No                 20                    3                      17                                                   Other                 Static limbs    1000                    4                      60                               63                     Average reference   N1, N2, LPP

  Cui *et al.,*[@ref19]                No                 22                    1                      22                                                   Passive observation   Static limbs    1000                    4                      240                              63                     Average reference   N1, P2, N2, P3

  Decety *et al.,*[@ref26]             Yes                30                    3                      15                                                   Passive observation   Static limbs    1000                    2                      150                              32                     Single mastoid      N110, P3

  Decety *et al.,*[@ref23]             Yes                38                    1                      19.5                                                 Pain assessment       Static limbs    1500                    4                      50                               64                     Average mastoids    Early, LPP

  Decety *et al.,*[@ref24]             No                 30                    6                      30                                                   Passive observation   Static limbs    2000                    4                      20                               32                     Average reference   N2, LPP, Slow wave

  Fabi *et al.,*[@ref28]               No                 16                    3                      16                                                   Pain detection        Static limbs    200                     4                      62                               72                     Average reference   P1, N1, N240, P3

  Fabi *et al.,* 2018                  No                 24                    1                      23                                                   Pain detection        Static limbs    400                     4                      60                               72                     Average reference   P1, N1, EPN, P3b

  Fallon *et al.,*[@ref29]             Yes                37                    0                      18.5                      Fibromyalgia               Pain assessment       Static limbs    3000                    2                      50                               64                     Average reference   P1, N1, P2, N2, P3, LPP

  Fan & Han, [@ref38]                  No                 26                    5                      26                                                   Pain detection        Static limbs    200                     8                      320                              64                     Average mastoids    N110, P180, N240, N340, P3, P1, N170, P320

  Fan *et al.,*[@ref31]                Yes                40                    18                     20                        Autism Spectrum Disorder   Pain detection        Dynamic limbs   2080                    4                      60                               32                     Average reference   N2, LPP

  Fitzgibbon *et al.,*[@ref32]         Yes                28                    0                      9.33                      Amputees\                  Pain assessment       Static limbs    3000                    4                      80                               64                     Average reference   N110, P180, N240, N340, P1, N170, P320, N3
                                                                                                                                 /Synaesthetes                                                                                                                                                                               
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Continued.

  Study                                  Between subjects   Sample size (total)   Number of exclusions   Sample size (per group)   Clinical sample    Task type         Stimulus type                   Simulus duration (ms)   Number of conditions   Number of trials per condition   Number of electrodes   EEG reference       Components analysed
  -------------------------------------- ------------------ --------------------- ---------------------- ------------------------- ------------------ ----------------- ------------------------------- ----------------------- ---------------------- -------------------------------- ---------------------- ------------------- --------------------------------------------
  Gonzalez-Liencres *et al.*, [@ref33]   Yes                39                    0                      19.5                      Schizophrenia      Pain detection    Static limbs                    500                     4                      24                               32                     Average mastoids    N110, P400, P1, P3
  Gonzalez-Liencres *et al.*, [@ref34]   Yes                60                    0                      15                                           Pain assessment   Static limbs                    750                     2                      70                               32                     Average mastoids    N110, P3
  Han *et al.*, [@ref38]                 Yes                26                    5                      13                                           Pain detection    Static limbs                    200                     4                      320                              64                     Average mastoids    N110, P180, N240, N340, P3, P1, N170, P320
  Ibáñez *et al.,*[@ref41]               No                 13                    0                      6.5                                          Pain detection    Static limbs                    500                     4                      40                               128                    Average mastoids    N1, P3
  Ikezawa *et al.*, [@ref42]             Yes                52                    0                      13                        Schizophrenia      Pain detection    Static limbs                                            4                      408                              32                     Average mastoids    N110, P180, P3a, P3b, P1, N170
  Ikezawa *et al.*, [@ref43]             No                 18                    0                      18                                           Pain detection    Static limbs                    350                     8                      102                              32                     Average mastoids    P3, LPP
  Jiang *et al.*, [@ref46]               Yes                36                    0                      18                                           Pain detection    Static limbs                    200                     6                      120                              64                     Average mastoids    N2, N320, P3
  Kam *et al.*, [@ref47]                 No                 19                    0                      19                                           Pain detection    Static limbs                    300                     8                      400                              64                     Not reported        Early, P3, LPP
  Li *et al.*, [@ref54]                  No                 24                    0                      24                                           Pain detection    Static limbs                    200                     4                      160                              64                     Average mastoids    N110, P160, N240, N320, P3
  Lyu *et al.*, [@ref56]                 No                 28                    4                      28                                           Pain assessment   Static limbs                    3000                    4                      74                               64                     Single mastoid      N1, P3
  Mella *et al.*, [@ref58]               Yes                29                    3                      14.5                                         Pain detection    Static limbs                    200                     4                      160                              64                     Average reference   N110, N340, LPP
  Meng *et al.*, [@ref59]                No                 20                    0                      20                                           Pain detection    Static limbs                    3000                    4                      135                              64                     Single mastoid      N1, P2, N2, P3, LPC
  Meng *et al.*, [@ref60]                No                 20                    0                      20                                           Pain assessment   Static limbs                    1000                    4                      60                               64                     Single mastoid      N1, P2, N2, P3, LPC
  Sessa *et al.,* 2013                   No                 12                    0                      12                                           Pain detection    Static faces                    250                     4                      240                              64                     Average earlobes    N1, P2, N2, N2-N3, P3
  Sun *et al.*, [@ref75]                 No                 36                    5                      31                                           Pain detection    Static limbs and static faces   250                     6                      150                              64                     Average mastoids    P1, N170, N1, P1, VPP, N2, LPC
  Suzuki *et al.*, [@ref76]              No                 15                    0                      15                                           Pain detection    Static limbs                    500                     4                      112                              32                     Average earlobes    N1, P2, N2, P310, P3
  Vaes *et al.,*[@ref78]                 Yes                18                    2                      9                                            Pain detection    Other                           250                     4                      90                               64                     Average earlobes    N1, P2, N2-N3, P3
  Wang *et al.,*[@ref80]                 No                 15                    2                      15                                           Pain detection    Static limbs                    1500                    4                      64.25                            66                     Average mastoids    N110, P300, LPP, N2
  Wexler *et al.,*[@ref81]               No                 37                    0                      18.5                      Schizophrenia      Pain detection    Static limbs                    500                     8                      102                              32                     Average reference   P3, LPP
  Yang *et al.*, [@ref82]                Yes                53                    0                      26.5                      Bipolar disorder   Pain detection    Static limbs                    1000                    4                      60                               64                     Average mastoids    N1, P3

![Proportion of studies as a function of the level of power to detect a small (*d* = 0.2), medium (*d* = 0.5) and large (*d* = 0.8) effect size.](nsy072f2){#f2}

Materials and procedure {#sec10}
-----------------------

### Visual stimuli {#sec11}

The majority of studies reviewed (82.5%) used static pictures depicting limbs (hands or feet) in painful and non-painful situations similar to those used initially by Jackson *et al.* ([@ref45]). The other types of stimuli included short three-frame clips of limbs in painful situations (7.5%), static pictures of faces pricked by a needle or touched with a cotton bud (5%), both faces and limbs (2.5%) and anthropomorphised objects pricked by a needle or touched with a cotton bud (2.5%). The average stimulus duration is shown in [Table 2](#TB2){ref-type="table"}.

### Experimental task {#sec12}

All studies compared ERPs to painful and non-painful stimuli. Including this pain factor, studies had an average of 2.08 within-subject factors (s.d. = 0.45; range, 1--3) and an average of 4.55 within-subject conditions (s.d. = 1.67; range, 2--8). During the experimental tasks, the participants were either asked to detect the presence of pain in a forced choice format (60% of studies), to assess the intensity of the pain observed using a rating scale (17.5%), to passively observe the pictures (15%) or to perform another behavioural task (7.5%). The average number of trials per condition is shown in [Table 2](#TB2){ref-type="table"}.

### Recordings {#sec13}

EEG was collected from 60 to 64 scalp electrodes in the majority of cases (70%) while the remaining studies used 32 (27.58%), 72 (5%) or 128 (5%) scalp electrodes. A total of 30% of the studies did not report the manufacturer of the EEG system used. The majority of studies (27.5 %) used an EEG system manufactured by *Brain Products*. Other manufacturers included *Biosemi* (BioSemi BV, Amsterdam, Netherlands) (27.5 %), *EGI Geodesic* (Electrical Geodesics Inc., Eugene, OR, USA) (5%) and *NuAmps* (Compumedics Neuroscan Inc., El Paso, TX) (10%).

### Preprocessing {#sec14}

EEG data were high-pass filtered in most cases with a cutoff value of 0.1 Hz (52.5%) and the rest of the studies used a high-pass cutoff between 0.01 and 1 Hz. For low-pass filters, the most used cutoffs were 100 and 30 Hz used in 30% and 40% of the cases, respectively. Other low-pass filter cutoffs included values between 40 and 80 Hz. Studies show that 7.5% and 5% did not report using a high-pass filter or a low-pass filter, respectively, while 5% reported using a notch filter to filter out electrical noise.

The average of the mastoid processes and the average of all scalp electrodes were the most popular reference schemes for EEG analyses (37.5% and 40%, respectively). Other studies use the average of the earlobes (7.5%), a single mastoid (12.5%) or did not report the reference used for analysis (2.5%). EEG data were epoched for analyses and in all cases the average pre-stimulus baseline was subtracted from the post-stimulus epoch. The duration of this baseline was on average 193.75 ms (s.d. = 28.17; range, 100--250). The average post-stimulus epoch duration is shown in [Figure 3C](#f3){ref-type="fig"}.

![(A) Percentage of studies reviewed using each type of artifact control procedure identified, (B) value of the rejection threshold if used and (C) duration of epochs.](nsy072f3){#f3}

All studies reported using at least one method to remove or correct for artifacts. Artifact rejection procedures included rejecting epochs by visual inspection or using a fixed amplitude threshold. Artifact correction procedures included removing components after independent component analysis or using various algorithms to remove electrooculogram (EOG) activity from the data. Some studies reported using additional filters to remove artifacts without providing further details. The percentage of studies using each of the main procedures is shown in [Figure 3A](#f3){ref-type="fig"}. Automatic rejection using a fixed threshold was the most used method and the average rejection threshold is shown in [Figure 3B](#f3){ref-type="fig"}. When using an artifact rejection procedure, 50% of studies reported the average number of epochs removed. On average, 11.34% of trials were removed (s.d. = 6.04; range, 1.34--29%).

ERP analyses {#sec15}
------------

### ERP selection and measurement {#sec16}

The average number of components analysed is shown in [Figure 4C](#f4){ref-type="fig"}. In most cases, the choice of ERP components to analyse was based on previous studies (72.5%), while other studies chose components based on the inspection of the grand average waveform (17.5%), used another analysis to select the components of interest (2.5%) or did not justify their selection of components (7.5%). As shown in [Figure 4A](#f4){ref-type="fig"}, the most widely analysed ERP components were the N1, N2, P2, P3 and LPP. Note that in some cases, slightly different names were used for these components (e.g. P320 instead of P3). Furthermore, some studies also performed several analyses on the same component (e.g. early and late LPP). See [Supplementary Table S1](https://osf.io/h6n4v) for the names and all components analysed in each study.

![(A) Number of components and locations analysed in each study. (B) Percentage of studies analysing each of the main component. (C) Percentage of studies analysing each scalp location. (D) Percentage of studies analysing each component analysing each time-point in the post-stimulus window.](nsy072f4){#f4}

The average number of locations analysed is shown in [Figure 4C](#f4){ref-type="fig"}, and the percentage of studies analysing each scalp location is shown on a 64-electrode montage in [Figure 4B](#f4){ref-type="fig"}. A minority of studies provided a justification for the choice of locations to analyse (40%) and in most cases this choice was based on previous studies (25%). Almost all studies quantified the ERP components using the mean amplitude within a time window (80%), while other studies used the peak amplitude within a time window (7.5%) or point-by-point analyses (i.e. performing analyses in small time windows covering the whole ERP epoch, 7.5%). One study used peak amplitude or mean amplitude depending on the component (5%). The choice of the time window to analyse was either based on visual inspection (47.5%), previous studies (22.5%) or both inspection and previous studies \[previous studies (5%) the data itself (i.e circular analyses, 15%) or not justified (10%)\]. The percentage of studies analysing each time point in the poststimulus window for each component is shown in [Figure 4D](#f4){ref-type="fig"}.

### ERP statistical analyses {#sec17}

Almost all studies used factorial ANOVAs to assess the statistical significance of the experimental factors on the ERPs (95%). One study used the analysis of covariance and another used the non-parametric Kruskal--Wallis test. Since the few studies using point-by-point analyses (7.5%) performed a large number of ANOVAs compared to the rest of the studies (on average 130 ANOVAs), these studies were not considered in the following description of the factorial analyses. Another study performing 54 ANOVAs was also considered an outlier and was not included in the descriptive statistics. The average number of ANOVAs performed in the remaining studies (*n* = 35) is shown in [Figure 5](#f5){ref-type="fig"}. These ANOVAs had an average of 3.2 factors (s.d. = 0.72; range, 2--5) and 19.6 cells (s.d. = 15.97; range, 4--60). To assess how many statistical tests these ANOVAs represent, the number of main effects and potential interactions was multiplied by the number of ANOVAs (Luck and Gaspelin, [@ref55]). The total number of tests in ANOVAs is shown in [Figure 5](#f5){ref-type="fig"}. No studies corrected the significance threshold for the total number of ANOVAs performed. However, some studies (60%) corrected the significance threshold when performing post-hoc comparisons using the Bonferroni (42.5%), Tukey (10%), Scheffe correction (5%) or false discovery rate (FDR) (2.5%) correction. Several studies used the Greenhouse--Geisser correction when performing repeated-measure analyses (52.5%).

![(A) Number of ANOVAs performed. (B) Total number of statistical tests performed using ANOVAs. (C) **N**umber of correlations. (D) Overall number of statistical tests performed.](nsy072f5){#f5}

In addition to the factorial analyses, correlations between ERP data and other behavioural, physiological or questionnaire measures, were performed in 65% of studies. The variables most frequently correlated with the ERP data were the four subscales of the Interpersonal Reactivity Index (Davis, [@ref20], 27.5% of studies) as well as subjective ratings of the intensity of the pain experienced by the models in the stimuli and of the unpleasantness experienced by the participant when watching these stimuli (27.5% of studies). These correlations either used the difference between the ERP amplitude in two conditions (32.5%), the mean amplitude in a particular condition (27.5%), both mean amplitude and peak amplitude (2.5%) or mean amplitude and peak latency (2.5%) and were often performed in multiple time windows and scalp locations. The average number of correlations per study is shown in [Figure 5](#f5){ref-type="fig"}. In 10% of the studies, the significance threshold was corrected to control for the possibility of a type 1 error in correlation analyses.

Results reporting {#sec18}
-----------------

A total of 92.5% of the studies reported mainly or exclusively significant results. When reporting the results from factorial analyses, 50% of the studies did not report any estimate of effect size, while the rest reported the partial eta squared (45%), Cohen's *d* (2.5%) or both (2.5%).

All but one study plotted the ERP data, 32.5% plotted only the time course of the ERP response, while 65% plotted both the time course and scalp maps at particular time points. In most cases, the locations and time points plotted were chosen because they were thought to be representative of the results (57.5%), while other studies plotted all locations analysed (25%) or only the locations showing significant effects (15%). On the time-course plots, only one study plotted the error intervals. In addition to the time course and scalp maps, 22.5% of studies also reported the ERP amplitudes in a table and 42.5% in bar graphs.

Meta-analysis of the effect of pain observation {#sec19}
-----------------------------------------------

The results from the meta-analysis of the effect of the observation of pain stimulation on the ERP components that were the most frequently analysed are shown in [Figures 6](#f6){ref-type="fig"} and [7](#f7){ref-type="fig"}. The complete set of forest plots for each component at each location is shown in Supplementary [Figures S1--S8](https://osf.io/h6n4v).

![(A) Scalp map of the average partial eta squared weighted by the number of studies reporting results at this electrode for the main effect of pain observation on each electrode and component. (B) Bar graph showing the proportion of studies included in the meta-analysis analysing each component, reporting a significant main effect of pain and a significant interaction between this effect and another factor.](nsy072f6){#f6}

![Forest plots showing the effect size and 90% CI for the effect of pain observation on the ERP amplitude at the frontal electrodes from the N1, N2, P3 and LPP components. Positive effects indicate higher (more positive) amplitudes for pain pictures and negative effects indicate lower (more negative) amplitudes for the pain pictures. Symbols show the type of stimulus used in each study (black square, static limbs; white square, dynamic limbs; white diamond, static faces; asterisk, other). Symbol size shows the relative sample size for this component/location.](nsy072f7){#f7}

### N1 component {#sec20}

The effect of pain observation on the N1 component is maximal at frontal electrodes ([Figure 6A](#f6){ref-type="fig"}). Although a minority of studies measuring this component found a significant effect of pain observation, several studies found a significant interaction between the effect of pain observation and another experimental factor ([Figure 6B](#f6){ref-type="fig"}). The random-effect meta-analytic model fitted on the effect of pain on the N1 component at fronto-central sites collected from 22 studies suggests the presence of a high heterogeneity in the effect sizes (Q = 94.67, df = 21, *P* \< 01, I^2^ = 79.37%). Overall, the random-effect model indicated that of pain observation on the N1 component at fronto-central sites is not significant \[*g* = 0.07; *k* = 22; *P* \< 01; 95% confidence interval (CI), −0.21 to 0.35\].

### N2 component {#sec21}

Similarly to the N1 component, the effect of pain observation on the N2 component is also maximal at frontal electrodes ([Figure 6A](#f6){ref-type="fig"}). Approximately 50% of the studies included in the meta-analysis found a significant effect and 27.78% found a significant interaction between the effect of pain and another experimental factor ([Figure 6B](#f6){ref-type="fig"}). There is an evidence for significant heterogeneity across the 20 studies (Q = 108.46; df = 19; *P* \< 01; I^2^ = 85.13%). Interestingly, the direction of the significant effects is highly heterogenous, with a similar number of studies finding a significant increase or decrease in amplitude during pain observation. This led to a non-significant overall effect of pain observation on the N2 component at fronto-central sites (*g* = 0.18; *k* = 20; *P* \< 01; I^2^ = 85.13; 95% CI, −0.15 to 0.5).

### P3 component {#sec22}

While the effects of pain observation on the P3 component are distributed across the scalp, the effect is maximal at centro-parietal sites. Most studies measuring this component found a significant effect and a significant interaction between the effect of pain and another experimental factor. Although the effect sizes for the P3 component across the 20 studies are considerably less heterogenous than those found for the early components, there is still significant heterogeneity across studies (Q = 55.78; df = 19; *P* \< 01; I^2^ = 66.33). All studies found that pain observation led to a positive shift in P3 amplitude and the overall effect is large and significant (*g* = 0.97; *k* = 20; *P* \< 01; 95% CI, 0.73--1.2).

### LPP component {#sec23}

The effect of pain observation on the LPP component is strongest at centro-parietal sites. As for the P3 component, most studies measuring this component found a significant effect of pain observation and 33.33% found a significant interaction between the effect of pain and another experimental factor. There is a significant heterogeneity across the 17 studies (Q = 63.62; df = 16; *P* \< 01; I^2^ = 76.39%), despite the fact that pain observation led to a positive shift in LPP amplitude for all studies. The overall effect of pain observation on the LPP is large and significant (*g* = 1.1; *k* = 17; *P* \< 01; 95% CI, 0.8195--1.39).

### Publication bias and excess significance {#sec24}

Funnel plots illustrating the effect size for each study as a function of study precision are shown in [Figure 8](#f8){ref-type="fig"}. It should be noted that the low variance in precision (due to most studies having a similar sample size) limits the interpretation of these figures. Nevertheless, the funnel plots show that the effect sizes were roughly symmetrically distributed across the summary effect size, suggesting the absence of publication bias. This observation was formally tested using linear regressions to assess the relationship between the magnitude of the effect size and the precision (standard error) of each study. This procedure revealed non-significant relationships between effect size and precision for the N1 component at fronto-central sites \[t(20) = 1.84; *P* = 0.08\], the N2 component at fronto-central sites \[t(18) = −0.76; *P* = 0.45) and the P3 component at centro-parietal sites \[t(18) = 1.46; *P* = 0.16\]. A significant negative relationship between effect sizes and precision is present for the LPP component at centro-parietal sites (b = 3.91; t(15) = 2.32; *P* = 0.03). This suggests that the large effect sizes found for the LPP component in some studies with a smaller sample size are likely inflated.

![Funnel plots showing the distribution of studies as a function of effect size and precision (standard error). The white area shows the 95% CI around the summary effect size for each degree of precision. Symbols show the type of stimulus used in each study (black square, static limbs; white square, dynamic limbs; white diamond, static faces; asterisk, other).](nsy072f8){#f8}

Exact binomial tests assessing the presence of excess significance suggest that the number of significant effects found for the N1 and N2 components is significantly higher than expected given the power of each study and the summary effect size (*P* \< 01 for both). The proportion of significant effects is, however, similar to the expected number for the P3 and LPP components (*P* \> 0.9 for both).

Discussion {#sec25}
==========

The meta-analysis of 36 studies investigating pain empathy using ERPs suggests that the observation of pain in others does not reliably modulate the early N1 and N2 components often measured in these studies. However, large and reliable effects were found for the latter P3 and LPP components.

These findings challenge a popular model arguing that the time course of the ERP to the observation of pain in others is characterised by an early frontal 'affective sharing response' followed by a centro-parietal 'late cognitive reappraisal' of the stimulus (Fan and Han, [@ref30]; Decety *et al.*, [@ref26]). Indeed, the current results suggest that the observation of pain in others does not lead to a reliable modulation of early frontal ERP components thus undermining the idea that they are associated with automatic emotion sharing. The absence of a reliable dissociation of early ERP responses to pain and neutral stimuli suggests that these stages instead reflect the perceptual processing of the stimulus that is necessary to assess its affective content and raises question regarding the commonly accepted time course of the processes involved in the empathic response. Indeed, the 'affective sharing response' to pain in others might not be as fast and as automatic and might rely more on the initial identification of the stimulus than previously thought (Coll *et al.*, [@ref11]).

Another possibility is that the vicarious pain stimuli used in the studies reviewed led to a modulation of an early posterior components that is generally observed for emotional stimuli (Schupp *et al.*, [@ref71],[@ref72]). Unfortunately, almost none of the studies reviewed reported early responses at posterior sites, thus preventing the comparison between ERP components that are claimed to reflect empathic processes and the components usually observed in response to emotional stimuli. Future research should further explore the influence of vicarious pain on early ERP components and the meaning of this effect by testing more thoroughly the spatial distribution of this effect and its relationship to other emotional ERP responses.

The results showed reliable effects of vicarious pain on the latter P3 and LPP components that are compatible with a wealth ERP research showing that emotional stimuli modulate the latter centro-parietal components (Schupp *et al.*, [@ref71]; Hajcak *et al.*, [@ref37]). The P3 and LPP responses are often interpreted in terms of sustained attentional processing and cognitive evaluation of motivationally relevant stimuli (Hajcak *et al.*, [@ref37]; Lang and Bradley, [@ref52]) that, in the context of empathy, might contribute to social understanding and emotional regulation (Decety *et al.*, [@ref26]; Cheng *et al.*, [@ref8]; Fan *et al.*, [@ref31]). The fact that the effect of pain observation on these components often interact with other experimental or between-subject factors suggest that this process is highly susceptible to interference and that its alteration in some groups reflects social--emotional difficulties. However, since this modulation is commonly observed in response to many types of emotional stimuli, the idea that it represents a specific process of the empathic response in the context of pain empathy and not a general aversive/regulatory response remains to be established. Indeed, none of the study reviewed compared the ERP response to vicarious pain stimuli to non-social--emotional stimuli to assess the specificity and uniqueness of the processes indexed (Happé *et al.*, [@ref39]). It therefore seems imperative for future studies using ERP to investigate pain empathy to carefully evaluate the validity, reliability and specificity of ERP responses to pain in others.

Despite the lack of reliability of the early frontal effects observed here, a considerable proportion of the studies reviewed report significant effects of pain observation on the early frontal N1 and N2 components. This apparent contradiction could be explained by the methodological issues underlined in the systematic review of methodological practices indicating that there was considerable variability in the quantification and statistical analysis of the ERP data. Indeed, while most studies used the mean amplitude between fixed latencies to quantify ERPs, the time windows and the electrode locations used for this measure often varied considerably across studies without a clear rationale underlying this choice. The problems of analytical flexibility, sometimes called researcher's degrees of freedom, have already been discussed elsewhere (Simmons *et al.*, [@ref74]; Luck and Gaspelin, [@ref55]). However, the current study suggests that previous investigations of pain empathy using ERPs might be compromised by this practice.

This analytical flexibility was often combined with a shotgun analytical approach in which a high number of statistical analyses were performed on several locations and time windows and any significant effect was interpreted as meaningful. On average, the studies reviewed here performed on average over 100 statistical tests on ERP data and none corrected the significance threshold to reduce the risk of a false-positive finding. This is problematic since such a high number of statistical tests leads to a high probability that several significant results are in fact false positives (Kilner, [@ref49]; Luck and Gaspelin, [@ref55]). To diminish this risk, researchers can use analytical techniques that can take into account the spatial and temporal distribution of ERP data to reduce the number of comparisons or to adequately control for them (Maris and Oostenveld, [@ref57]; Groppe *et al.*, [@ref36]; Pernet *et al.*, [@ref65]).

Alternatively, researchers can restrict their analyses to scalp regions and time windows for which an effect was predicted. However, a worrying result of this study is the fact that in several cases, the analysis and interpretation of the data were not constrained by the researchers' predictions since no clear hypotheses were formulated. This suggests that despite using the confirmatory analytical approach of null hypothesis significance testing, most of ERP research in the field of pain empathy is exploratory (Wagenmakers *et al.*, [@ref79]), even after 10 years and 40 studies. A solution to this issue would be to require researchers to clearly formulate their research hypotheses and label as exploratory the results of analyses that were not predicted. Ideally, researchers could pre-register their hypotheses online or publish using the pre-registered report format to establish the analysis plan before collecting data (Munafo *et al.*, [@ref63]).

Another striking observation permitted by this review is the lack of comprehensive reporting for the results from the statistical analysis of ERP components. Indeed, it was found that the vast majority of the studies only reported significant results from a large number of factorial analyses. Therefore, in addition to a potential publication bias (Rosenthal, [@ref70]), the ERP studies reviewed here also show a within-study reporting bias according to which analyses leading to non-significant results are less likely to be reported. Putting aside the fact that negative results can sometimes be informative if statistical power is high enough (Greenwald, [@ref35]), the main consequence of this practice is that any attempt to meta-analytically summarise the results of such studies will be difficult, inevitably biased and of questionable usefulness (Moran *et al.*, [@ref62]). Therefore, it should be noted that the effect size calculated in the meta-analysis performed in this report are probably inflated. In several cases, this practice was justified by the necessity to provide a concise and brief report of the results. The short-term solution to this issue is to make it mandatory for authors to appropriately report all the results of all statistical analyses performed on ERP components in the text or in Supplementary Materials. It would also be beneficial for the field of ERP research to adopt a standard reporting procedure that would enable the automatic extraction of results from published articles and facilitate meta-analyses and large-scale automated summaries of all published studies. For example, the field of functional magnetic resonance imaging research has taken advantage of the standard reporting of activation coordinates in tables to produce automated meta-analytical tools (Yarkoni *et al.*, [@ref83]). A more preferable long-term solution would be to favorise the sharing of ERP data in online repository that would allow the reanalysis and meta-analysis of large data sets and a quick and efficient assessment of the evidence for specific effects (Poldrack and Gorgolewski, [@ref68]).

A related issue to the incomplete reporting of results was incomplete and unclear reporting of several important methodological details. For example, less than half of the studies reported the number of trials left after artifact rejection procedures, meaning that it was unknown how many trials were included in the analyses in a majority of cases. To avoid omitting to report such crucial information, researchers should refer to published guidelines for reporting of EEG experiments (Picton *et al.*, [@ref66]; Keil *et al.*, [@ref48]; Moran [*et al.*]{.ul}, [@ref62]) and reviewers should enforce these guidelines in all relevant cases.

Finally, an estimation of the statistical power for each study revealed that most studies reviewed were only adequately powered to detect large effect sizes. The lack of consideration for statistical power in ERP research has been discussed previously. Future research should provide adequate justifications for their sample sizes (see Larson and Carbine, 2017 for a review and suggestions). Low statistical power can not only prevent the detection of small effects (type 2 error) but may also lead to an imprecise estimation of the effect sizes and to type 1 errors (Button *et al.*, [@ref87]). This imprecise estimation of the effect sizes could have contributed to the excess significance and heterogeneous effect sizes observed for the early components. Because of this and the issue of selective reporting discussed above, the results from the meta-analysis are most likely biased. This means that while they can be used to roughly guide future investigations, the precise value of the meta-analytic effect sizes reported here should not be taken at face value. Ideally, future investigations should consider adopting a level of statistical power that allows the detection of the smallest effect size of interest (see Lakens, [@ref51] for a discussion of the smallest effect size of interest). Other factors such as the signal-to-noise ratio can also contribute to statistical power and should be considered when planning ERP experiments (Boudewyn *et al.*, [@ref3]).

Limitations {#sec26}
-----------

The high heterogeneity in the experimental designs and analytical approaches as well as partial reporting of results in the studies analysed prevented an analysis of factors modulating the ERPs to vicarious pain. It is therefore possible that the lack of effect found for the early components is due to a moderation by other factors that could not be assessed. For example, the impact of the nature of the stimuli used (e.g. limbs versus faces) on the ERP responses should be carefully investigated in future studies. The improvement of methods and reporting in future studies should allow a more comprehensive analysis of such factors potentially modulating the effects observed.

The methodological issues highlighted in this report are not specific to the domain of pain empathy and the present observations could potentially be generalised to many other fields of research in cognitive neuroscience (e.g. Hobson and Bishop, [@ref40] for similar observations on EEG studies of action observation). Furthermore, while several issues were found to be prevalent in the studies reviewed, the scientific quality and usefulness of all papers cited in this report should be assessed on an individual basis. Finally, the solutions proposed to the issues raised are not exhaustive, nor can they be applied indiscriminately to all ERP research.

Conclusion {#sec27}
==========

In conclusion, this study provides meta-analytic evidence for a robust modulation of the latter, but not early ERP components during pain observation. Furthermore, it suggests that the current framework used in pain empathy research using ERPs is undermined by several methodological problems that raise doubts regarding the reliability, validity and overall usefulness of this research. Researchers in the field should take into account the methodological issues raised here when designing and reviewing ERP experiments. This is of critical importance if this paradigm is to be used to draw conclusions on socioal--emotional functioning in different clinical populations.
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